finance

Antimicrobial resistance spin-out prepares for next funding round




The Glasgow-based business is moving into the next stage of clinical testing and is seeking lead investors from overseas



READ SOURCE

Readers Also Like:  McGill’s Group appoints managing director

This website uses cookies. By continuing to use this site, you accept our use of cookies.